Care of Women with Obesity in Pregnancy
Background and Scope
Maternal obesity is common in the UK obstetric population — RCOG cites 21.3% of the antenatal population as obese, with fewer than half of pregnant women (47.3%) having a BMI in the normal range. The guideline's recommendations apply mainly to women with a booking or pre-pregnancy BMI of 30 kg/m² or greater, though several recommendations are specific to higher obesity classes. Standard WHO obesity classes are used for risk stratification:
- Class I: BMI 30.0–34.9 kg/m²
- Class II: BMI 35.0–39.9 kg/m²
- Class III: BMI ≥40 kg/m²
The chosen cut-offs reflect a balance between medical intervention, local prevalence of maternal obesity, and resource implications for maternity units. Recommendations span pre-conception, antenatal, intrapartum, and postnatal care.
Associated Risks
Compared with women of normal BMI, obese pregnant women are at greater risk of:
- Pre-eclampsia
- Gestational diabetes
- Caesarean birth
- Venous thromboembolism (VTE) — a BMI of 30 kg/m² or greater, pre-pregnancy or at booking, is itself a pre-existing VTE risk factor requiring formal risk assessment
- Difficulties with fetal assessment: sizing, presentation, and fetal heart rate monitoring can all be technically compromised by increased maternal adiposity
- Breastfeeding difficulties postnatally
Pre-Conception and Antenatal Care
- Women with a BMI of 30 kg/m² or greater who wish to conceive should be advised to take 5 mg folic acid daily, started at least one month before conception and continued through the first trimester (higher than the standard 400 microgram dose used in the general population).
- Ultrasound assessment (dating, anomaly, and growth scanning) is recognised as technically more difficult in women with obesity, as increased adipose tissue reduces image quality; additional or repeat views may be needed to achieve adequate diagnostic images.
- VTE risk should be formally assessed at booking (and reassessed as pregnancy progresses and around delivery), given that BMI ≥30 kg/m² is itself a contributing risk factor.
- Anaesthetic difficulties should be anticipated and planned for — the guideline flags likely difficulties with venous access and with both regional and general anaesthesia as pregnancy progresses.
Intrapartum and Anaesthetic Considerations
- Women with a BMI of 35 kg/m² or greater should have multidisciplinary input, a documented antenatal discussion of intrapartum risks, and be advised to give birth in a consultant-led unit with appropriate anaesthetic and neonatal support on site.
- Women with a BMI of 40 kg/m² or greater represent the highest-risk anaesthetic group; antenatal assessment by an obstetric anaesthetist is recommended for this group, so that plans for analgesia/anaesthesia, venous access, and equipment needs are made in advance of labour rather than at the point of an emergency.
- Anticipated difficulties include venous access, siting of regional anaesthesia, and airway management for general anaesthesia — all of which underpin the case for early, planned anaesthetic review rather than reactive management in labour.
High-Yield Exam Points
- BMI ≥30 kg/m² is the general threshold for GTG 72 recommendations to apply; obesity classes I/II/III are defined at 30–34.9 / 35–39.9 / ≥40 kg/m².
- BMI ≥30 kg/m² alone is a pre-existing VTE risk factor requiring formal antenatal assessment.
- BMI ≥30 kg/m² wishing to conceive → 5 mg folic acid daily from ≥1 month pre-conception through the first trimester.
- BMI ≥35 kg/m² → advise birth in a consultant-led unit with multidisciplinary, documented antenatal planning.
- BMI ≥40 kg/m² → antenatal anaesthetic assessment recommended, reflecting the highest anticipated risk of anaesthetic complications (venous access, regional technique failure, difficult airway).
- Obesity independently increases risk of pre-eclampsia, gestational diabetes, and caesarean birth, and can degrade the quality of ultrasound fetal assessment and intrapartum fetal monitoring.
MRCOG AI is an independent educational tool. It is not affiliated with, endorsed by, or connected to the Royal College of Obstetricians and Gynaecologists (RCOG). This summary is derived from the publicly available RCOG Green-top Guideline No. 72 landing page and corroborating secondary sources; readers should consult the full guideline text for complete, graded recommendations.
Source: RCOG Green-top Guideline No. 72 (22 November 2018 (publication date per RCOG website; no subsequent update noted on the official guidance page as of this writing))
Read the original on rcog.org.uk
MRCOG AI is an independent educational tool. It is not affiliated with, endorsed by, or connected to the Royal College of Obstetricians and Gynaecologists (RCOG).